Clinical Trials Browser

Phase 2 × INDUSTRY × obatoclax × Clear all

NCT00427856 2016-07-22

Safety and Efficacy of Single Agent Obatoclax Mesylate (GX15-070MS) Followed by a Combination With Rituximab for Previously-untreated Follicular Lymphoma (FL)

Phase 2 Completed

Lymphoma, Follicular

NCT00684918 2013-08-26

Study of Obatoclax in Previously Untreated Acute Myeloid Leukemia (AML)

Phase 2 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute